Programmed cell death protein1 (PD1)-expression in the microenvironment of classical Hodgkin lymphoma at relapse after conventional chemotherapy and at relapse on anti-PD1 treatment

被引：4
|
作者：
Sasse, Stephanie [1 ,2 ]
Reddemann, Katharina [3 ]
Diepstra, Arjan [4 ]
Borchmann, Sven [1 ,2 ,5 ,6 ]
Oschlies, Ilske [3 ]
Schnitter, Antje [3 ]
Engert, Andreas [1 ,2 ]
Borchmann, Peter [1 ,2 ]
Klapper, Wolfram [3 ]
机构：
[1] Univ Hosp Cologne, Dept Internal Med 1, Cologne, Germany
[2] Univ Hosp Cologne, German Hodgkin Study Grp, Cologne, Germany
[3] Univ Kiel, Univ Hosp Schleswig Holstein, Hematopathol Sect, Dept Pathol, Kiel, Germany
[4] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Groningen, Netherlands
[5] Univ Hosp Cologne, Ctr Mol Med, Cologne, Germany
[6] Univ Cologne, Else Kroner Forsch Kolleg Cologne, Cologne, Germany
来源：
HAEMATOLOGICA | 2019年 / 104卷 / 01期
关键词：
D O I：
10.3324/haematol.2018.207829
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E45 / E46
页数：2
相关论文
共 50 条
  • [31] Kinetics and nadir of responses to immune checkpoint blockade by anti-PD1 in patients with classical Hodgkin lymphoma
    Dercle, Laurent
    Ammari, Samy
    Seban, Romain-David
    Schwartz, Lawrence H.
    Houot, Roch
    Labaied, Nizar
    Mokrane, Fatima-Zohra
    Lazarovici, Julien
    Danu, Alina
    Marabelle, Aurelien
    Ribrag, Vincent
    Michot, Jean-Marie
    EUROPEAN JOURNAL OF CANCER, 2018, 91 : 136 - 144
  • [32] Different expression of programmed death 1 (PD1) and its ligand (PD-L1) in esophageal and gastric cancer
    Daster, Silvio
    Eppenberger-Castori, Serenella
    Droeser, Raoul A.
    Schaefer, Hannah M.
    Spagnoli, Giulio C.
    Terracciano, Luigi
    Tornillo, Luigi
    von Holzen, Urs
    CANCER RESEARCH, 2016, 76
  • [33] Programmed cell death protein 1 (PD-1) in infection
    Leth, Steffen
    Jensen-Fangel, Soren
    APMIS, 2020, 128 (02) : 177 - 187
  • [34] lTumor Microenvironment in Patients with Relapsed/Refractory Classical Hodgkin Lymphoma before and after Anti-PD-1 Therapy
    Gusak, Artem A.
    Lepik, Kirill V.
    Mikhailova, Natalia B.
    Kondakova, Elena
    Zalaylov, Yuri R.
    Popova, Marina O.
    Ionova, Tatiana I.
    Kulagin, Aleksandr D.
    Afanasyev, Boris V.
    Baykov, Vadim
    BLOOD, 2020, 136
  • [35] Tumoral programmed cell death 1 (PD1) expression in endometrial carcinoma is a prognostic marker for patient outcome
    Feroz, Barin
    Pan, Teresa L.
    Leitner, Katharina
    Ebner, Christoph
    Steger, Katharina
    Kildal, Wanja
    Kristensen, Gunnar
    Zeimet, Alain Gustave
    Hackl, Hubert
    Fiegl, Heidi
    Marth, Christian
    Wieser, Verena
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024, 34 (11) : 1711 - 1718
  • [36] Phase 2 Trial of Anti-PD1 and 8 Gy in 1 Fraction for Relapse/ Refractory Myeloma
    Khan, M. K.
    Nasti, T.
    Kleber, T.
    Qian, J. Y.
    Switchenko, J.
    Hess, C. B.
    Jonathan, K.
    Nooka, A.
    Lonial, S.
    Ahmed, R.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : S108 - S108
  • [37] A Threshold Level of Intratumor CD8+ T-cell PD1 Expression Dictates Therapeutic Response to Anti-PD1
    Ngiow, Shin Foong
    Young, Arabella
    Jacquelot, Nicolas
    Yamazaki, Takahiro
    Enot, David
    Zitvogel, Laurence
    Smyth, Mark J.
    CANCER RESEARCH, 2015, 75 (18) : 3800 - 3811
  • [38] Melanoma PD1 expression is upregulated by MAPK inhibitors leading to an immune-independent synergism with anti-PD1 antibodies
    Sanlorenzo, Martina
    Vujic, Igor
    Floris, Arianna
    Novelli, Mauro
    Donini, Chiara
    Gammaitoni, Loretta
    Giraudo, Lidia
    Macagno, Marco
    Quaglino, Pietro
    Fierro, Maria Teresa
    Giordano, Silvia
    Carnevale-Schianca, Fabrizio
    Aglietta, Massimo
    Sangiolo, Dario
    CANCER RESEARCH, 2017, 77
  • [39] Beyond Exhaustion: The PDL1-PD1 Axis Shapes the Classical Hodgkin Lymphoma Microenvironment
    Taylor, Joseph G.
    Clear, Andrew James
    Truelove, Edward
    Calaminici, Mariarita
    Gribben, John G.
    BLOOD, 2019, 134
  • [40] Programmed Death Ligand 1 Expression in Classical Hodgkin Lymphoma in Pediatric Patients
    Aoki, Takahiro
    Kyushiki, Masashi
    Kishimoto, Hiroshi
    Yanagi, Masato
    Mori, Makiko
    Arakawa, Yuki
    Hino, Moeko
    Shimojo, Naoki
    Koh, Katsuyoshi
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2018, 40 (04) : 334 - 335
12345